Aspirin Use in Atrial Fibrillation Patients

 

Atrial Fibrillation pic
Atrial Fibrillation
Image: heart.org

After receiving his doctor of medicine in neuroscience in 1994 from the University of Birmingham, Sanjiv Narayan Abbott went on to a career in medicine with a focus on research and education. Currently a professor of medicine at Stanford, Sanjiv Narayan Abbott works in the San Francisco Bay area and treats Atrial Fibrillation.

Atrial fibrillation (AF), the most common form of arrhythmia, is characterized by an erratic heartbeat that is often too fast. It can increase the risk of stroke and heart failure. Despite data proving that blood thinners are superior to treating the condition, research published in the Journal of the American College of Cardiology indicates that about 40% of AF patients at intermediate to high risk for stroke are treated with only aspirin.

Earlier studies have shown that warfarin (oral blood thinner) reduced thromboembolism (blood clot obstructing blood vessel) better than aspirin. According to Jonathan C. Hsu, MD, cardiologist at UC San Diego Health, aspirin alone is not very effective in stroke prevention, and the risk of intracranial hemorrhage remains.

Advertisements

The Heart Rhythm Society Hosts Heart Rhythm Scientific Sessions

Heart Rhythm Society pic
Heart Rhythm Society
Image: hrsonline.org

As a professor of medicine at Stanford University and a practicing cardiologist, Dr. Sanjiv Narayan specializes in treating patients with heart rhythm disorders. As a pioneer in his field, Dr. Sanjiv Narayan developed an innovative new approach to treating atrial fibrillation called FIRM, which was recently acquired by Abbott Laboratories. In addition to his affiliation with Abbott, Dr. Narayan is a member of several professional organizations, including the Heart Rhythm Society, of which he has been a fellow since 2008.

The Heart Rhythm Society serves professionals who focus on cardiac rhythm disorders. Each year, the organization holds an annual meeting, the Heart Rhythm Scientific Sessions. The 2017 meeting will take place at McCormick Place in Chicago from May 10-13th.

The event gives cardiac medical professionals an opportunity to network with their peers as well as to participate in educational sessions covering topics such as defibrillation, ablation, pharmacology, and genetics. For those who wish to focus their educational experience at the meeting, specific programs are offered for fellows-in-training, physicians concerned with pediatric and adult congenital heart diseases, and genetic counselors.

Hugh Evans, co-founder and CEO of Global Citizen/Global Poverty Project, is scheduled to be the plenary speaker for the 2017 event. Evans will speak on “Becoming a Citizen of the World” and will encourage attendees to mobilize and work together to end global problems like extreme poverty, climate change, and gender inequality.